Nicotine - the sine qua non of smoking

John (Gold)
John (Gold)

3:14 AM - Jul 27, 2003 #1

It's Freedom's policy that this forum not be used to vilify those engaged in the lawful manufacture and sale of nicotine products as it does nothing to further our mission of helping all members remain nicotine free today, including members whose jobs involve the harvest, production, marketing and/or sale of nicotine products. That being said, Freedom will not hide industry knowledge beneficial to dependency understanding.  Just one rule - no nicotine today, Never Take Another Puff! John

Nicotine ... the Sine Qua Non of Smoking
April 14, 1972 R.J. Reynolds Confidential Research
Planning Memorandum on the Nature of the Tobacco
Business and the Crucial Role of Nicotine Therein
By Claude Teague, Jr.
R.J. Reynolds Assistant Director of Research

[Note: brackets contain original memo language]

MEMORANDUM: In a sense, the tobacco industry may be thought of as being a specialized, highly ritualized and stylized segment of the pharmaceutical industry. Tobacco products, uniquely, contain and deliver nicotine, a potent drug with a variety of physiological effects. Related alkaloids, and probably other compounds, with desired physiological effects are also present in tobacco and/or its smoke. Nicotine is alleged [known] to be a habit-forming alkaloid, hence the confirmed user of tobacco products maybe [is] primarily seeking the physiological "satisfaction" derived from nicotine -- and perhaps other active compounds. His choice of product and pattern of usage are primarily determined by his individual nicotine dosage requirements and secondarily by a variety of other considerations including flavor and irritancy of the product, social patterns and needs, physical and manipulative gratifications, convenience, cost, health considerations, and the like. Thus a tobacco product is, in essence, a vehicle for delivery of nicotine, designed to deliver the nicotine in a generally acceptable and attractive form. Our Industry is then based upon design, manufacture and sale of attractive dosage forms of nicotine, and our Company's position in our Industry is determined by our ability to produce dosage forms of nicotine which have more overall value, tangible or intangible, to the consumer than those of our competitors.

The habituated user of tobacco products is said to derive "satisfaction" from nicotine. Although much studied, the physiological actions of nicotine are still poorly understood and appear to be many and varied. For example, in different situations and at different dose levels, nicotine appears to act as a stimulant, depressant, tranquilizer, psychic energizer, appetite reducer, anti-fatigue agent, or energizer, to name but a few of the varied and often contradictory effects attributed to it. Many of these same effects may be achieved with other physiologically active materials such as caffeine, alcohol, tranquilizers, sedatives, euphorics, and the like. Therefore, in addition to competing with products of the tobacco industry, our products may, in a sense, compete with a variety of other products with certain types of drug action. All of these products, tobacco and other, appear to have certain common attributes in that they are used largely to relieve, in one way or another, the fatigues and stresses which arise in the course of existence in a complex society.

Happily for the tobacco industry, nicotine is [both habituating and] unique in its variety of physiological actions, hence no other active material or combination of materials provides equivalent "satisfaction". Whether nicotine will, over the long term, maintain its unique position is subject to some reasonable doubt. With increased sophistication of knowledge in the biological and pharmaceutical areas, a superior or at least equivalent product or product mixture may emerge. For this reason, it would be a mistake to assume that the tobacco industry, as we now know it, is immortal or that no direct competition from organizations outside of the tobacco Industry will ever occur. It is safe to assume, however, that nicotine will retain its unique position throughout the present ten year planning period, and probably for a much longer span of time.

If nicotine is the sine qua non of tobacco products and tobacco products are recognized as being attractive dosage forms of nicotine, then it is logical to design our products -- and where possible, our advertising -- around nicotine delivery rather than "tar" delivery or flavor. To do this we need to develop new data on such things as the physiological effects of nicotine, the rate of absorption and elimination of nicotine delivered in different doses at different frequencies and by different routes, and ways of enhancing or diminishing nicotine effects and "satisfactions". In the absence of such data, we may survey the market and conclude that current cigarette products delivering about 1.3 mg. of nicotine appear to "satisfy" the typical smoker. This, somewhat crudely, establishes a target dosage level for design of new products. An accompanying Research Planning Proposal describes that approach in some detail. However, if we knew more about nicotine absorption, action, elimination, enhancement and the like, it should, in theory, be possible to more precisely specify, and deliver, the optimum amounts of nicotine activity in sophisticated products which would be more satisfying and desirable to the user. This area merits consideration and activity.

Before proceeding too far in the direction of design of dosage forms for nicotine, it may be well to consider another aspect of our business; that is, the factors which induce a pre-smoker or non-smoker to become a habituated smoker. Paradoxically, the things which keep a confirmed smoker habituated and "satisfied", i.e., nicotine and secondary physical and manipulative gratifications, are unknown and/or largely unexplained to the non-smoker. He does not start smoking to obtain undefined physiological gratifications or reliefs, and certainly he does not start to smoke to satisfy a non-existent craving for nicotine. Rather, he appears to start to smoke for purely psychological reasons -- to emulate a valued image, to conform, to experiment, to defy, to be daring, to have something to do with his hands, and the like. Only after experiencing smoking for some period of time do the physiological "satisfactions" and habituation become apparent and needed. Indeed, the first smoking experiences are often unpleasant until a tolerance for nicotine has been developed. This leaves us, then, in the position of attempting to design and promote the same product to two different types of market with two different sets of motivations, needs and expectations. The same situation is encountered in some industries, but the problem is usually not as severe.

If what we have said about the habituated smoker is true, then products designed for him should emphasize nicotine, nicotine delivery efficiency, nicotine satisfaction, and the like. What we should really make and sell would be the proper dosage form of nicotine with as many other built-in attractions and gratifications as possible -- that is, an efficient nicotine delivery system with satisfactory flavor, mildness, convenience, cost, etc. On the other hand, if we are to attract the non-smoker or pre-smoker, there is nothing in this type of product that he would currently understand or desire. We have deliberately played down the role of nicotine, hence the non-smoker has little or no knowledge of what satisfactions it may offer him, and no desire to try it. Instead, we somehow must convince him with wholly irrational reasons that he should try smoking, in the hope that he will for himself then discover the real "satisfactions" obtainable. And, of course, in the present advertising climate, our opportunities to talk to the pre-smoker are increasingly limited, and therefore, increasingly ineffective. Would it not be better, in the long run, to identify in our own minds and in the minds of our customers what we are really selling, i.e., nicotine satisfaction? This would enable us to speak directly of the virtues of our product to the confirmed smoker, and would educate the pre-smoker, perhaps indirectly but effectively, in what we have to offer and what it would be expected to do for him.

But again, the picture is not quite all that clear. Critics of tobacco products increasingly allege that smoking is dangerous to the health of the smoker. Part of this alleged danger is claimed to arise from ingestion of nicotine and part is claimed to arise from smoke components or smoke "tar". If, as proposed above, nicotine is the sine qua non of smoking, and if we meekly accept the allegations of our critics and move toward reduction or elimination of nicotine from our products, then we shall eventually liquidate out business. If we intend to remain in business and our business is the manufacture and sale of dosage forms of nicotine, then at some point we must make a stand. We should know more, rather than less, than our critics about the physiological effects of nicotine, and we should in all ways scientifically validate and speak to the beneficial effects and "satisfactions" derived from use of nicotine. Essentially all commercial drugs give rise to some undesirable side effects, but we continue to use them with great benefit to humanity because of their overriding beneficial effects. Might we not take a leaf from that book in our approach to nicotine? Unless we do, our long-term prospects become unattractive.

Our critics have lumped "tar" and nicotine together in their allegations about health hazards, perhaps because "tar" and nicotine are generated together in varying proportions when tobacco is smoked. An accompanying Research Planning Memorandum suggests an approach to reducing the amount of "tar" in cigarette smoke per unit of nicotine. That is probably the most realistic approach in today's market for conventlonal cigarette products. However, another more futuristic approach is possible which goes more directly to the fundamentals of the alleged problem.

If our business is fundamentally that of supplying nicotine in useful dosage form, why is it really necessary that allegedly harmful "tar" accompany that nicotine? There should be some simpler, "cleaner", more efficient and direct way to provide the desired nicotine dosage than the present system involving combustion of tobacco or even chewing of tobacco. A conventional 1000 mg. tobacco rod containing about 20 mg. of nicotine is smoked to produce only about 1.3 mg of smoke nicotine, accompanied by about 20 mg. of "tar" and 20 mg. of gas phase matter; and a [substantial] part of the 1.3 mg of smoke nicotine is lost to the smoker via exhaled smoke -- surely an inefficient nicotine delivery system. It should be possible to obtain pure nicotine by synthesis or from high-nicotine tobacco. It should then be possible, using modifications of techniques developed by the pharmaceutical and other industries, to deliver that nicotine to the user in efficient, effective, attractive dosage form, accompanied by no "tar", gas phase, or other allegedly harmful substances. The dosage form could incorporate various flavorants, enhancers, and like desirable additives, and would be designed to deliver the minimum effective amount of nicotine at the desired release-rate to supply the "satisfaction" desired by the user. Such a product would maximize the benefits derived from nicotine, minimize a11egedly undesirable over-dosage side effects from nicotine, and elimlnate exposure to other materials alleged to be harmful to the user. For the long term, we should be working toward development of such products -- if we do not, inevitably someone else will, and there are strong indications that others are already moving in this direction.

In the present real situation, where nothing has been done to counteract the adverse allegations about nicotine and where conventional products delivering adequate amounts of nicotine dominate the marketplace, no abrupt change in our posture or strategy would be appropriate or reasonable. The approaches advocated above are aimed at stopping and eventually reversing a trend that may in the long term put us out of business, and are intended to lay a framework of philosophy around which research efforts may now begin. Hopefully, some day we will rejotce rather than despair when a new crop of tobacco shows an unusually high content of nicotine, our primary product. Hopefully, with time we will be able to develop sophisticated and improved minimum dosage forms for nicotine which will be more satisfying to the user and free of alleged health hazards. And hopefully, by that time, we will have been able to establish and use information showing that use of nicotine fills real, demonstrable human needs, the beneficial effects overriding the allegedly harmful side effects.


If the above is a valid line of reasoning, then our long-term future courses of action should be as follow:
  • 1. Recognize the key role of nicotine in consumer satisfaction, and design and promote our products with this in mind.
  • 2. More precisely define the minimum amount of nicotine required for "satisfaction" in terms of dose levels, dose frequency, dosage form, and the like. This would involve biological and other experiments.
  • 3. Sponsor in-depth studies of the physiologlcal, psychological and other effects of nicotine, aimed at demonstrating the beneficial effects of nicotine and at disproving allegations that nicotine produces major adverse effects.
  • 4. Study, design and evaluate new or improved systems for delivery of nicotine which will provide the minimum satisfying amount of nicotine in attractive form, free of allegedly harmful combustion products.
  • 5. Study means for enhancing nicotine satisfaction via synergists, alteration of pH, or other means, to minimize dose level and maximize desired effects.
  • 6. Monitor developments in materlals and products which may compete with nicotine products or which might be combined with nicotine products to provide added advantages or satisfactions.
  • 7. Monitor work by others which might be aimed at improved nicotine delivery systems of the type proposed here.
  • 8. Search for and evaluate other physiologically active components of tobacco or its smoke which may provide desired effects to the smoker.
Signed, Claude E. Teague, Jr.
April 14, 1972
Last edited by John (Gold) on 11:32 AM - Jun 14, 2010, edited 3 times in total.

John (Gold)
John (Gold)

4:33 AM - Jul 27, 2003 #2

'Super-addictive' cigarette probe
BBC News UK Edition, Friday, July 25, 2003
Some cigarettes may deliver a 20 times more powerful nicotine "kick" than others, according to researchers.

On first inspection, the bulk of different cigarette brands have roughly the same amount of nicotine in them.

However, it does not mean that the habit-forming chemical is delivered to the smoker in the same way.

Some produce a far higher amount of nicotine in a "free-base" form, which is more quickly absorbed by the smoker and produces the characteristic "kick".

The research, by a team at Oregon Health and Science University, tested smoke from 11 brands of cigarettes purchased across the US.

They were tested against what is described as a "standard" cigarette - a cigarette manufactured to exact standards and used only in smoking research.

Their results could help rate the "addictiveness" of various cigarette brands.

Easily absorbed

Nicotine is carried into the smoker's body on the billions of particles in cigarette smoke.

The chemical can appear in two forms - free-base and non free-base.

The free-base form of nicotine is better able to be vaporised into a gas during smoking.

This means it can be more easily absorbed by the lungs, from where it is transported to the brain.

The first three "puffs" from each cigarette on test were measured.

Big differences

The "standard" cigarette only had approximately 1% of the nicotine in the first few puffs in the free-base form.

The highest brand - a speciality cigarette - had a massive 36%.

One type of Marlboro had 10% free-base nicotine, and the levels varied widely between all the brands tested.

Professor James Pankow, who led the study, said: "We believe that this study is a major step forward in understanding how addictive nicotine is delivered by tobacco smoke.

"We found big differences in the percentages of free-base nicotine among the 11 brands."

The findings, if repeated, could provide ammunition for action against the brands of cigarette which might prove most addictive.

The tobacco industry has been resisting efforts by governments - in particular the Netherlands - to make them disclose the exact formulation of their cigarettes.

The head of the Cancer Institute at the University, Dr Grover Bagby, said: "Cigarette smoking is the single most preventable cause of morbidity and mortality in the United States.

"Understanding the chemical elements that form the basis of addiction is an important step forward in developing ways of conquering this problem in our society today."

The research was published in the journal Chemical Research.

Copyright 2003 BBC News - UK Edition


4:36 AM - Jul 27, 2003 #3

Hi john
Thanks for bringing this up,i have noticed people in their posts since i came here berating tobacco companies and i understand that there could be nicotine addicts involved in these many products,i don,t think anger at suppliers helps quits,i believe we have to look to ourselves and learn from our addiction and not look for blame outside or look to blame ourselves.tobacco companies did not write the law of addiction,there are many drugs that fall under the umbrella of the law of addiction at different levels,if everyone stops smoking then the companies will cease to exist and the law of business is supply and demand which means that if demand falls then they will look at other business ideas,it does,nt matter to our quits about advertising and fancy packaging,infact packaging in the uk states very boldly that smoking kills and i,m still seeing people smoke and thats because they think they choose to and they don,t understand nicotine addiction,i,ve no doubt that the labels have motivated people to think about quitting,but we are here to quit cold turkey and we are here to support a nicotine free life and all its benefits.addictions have been here since the beginning of time,many plants have had addicted substances made from them throughtout history,it just so happens that nicotine is one of the most addictive and our fight is not with suppliers our battle is with learning about the addiction and beating it.


4:37 AM - Jul 27, 2003 #4

Thank you for the very informative post, John. It's so nice to know the industry has our best interests in mind. Hopefully, this will fall somewhat under the category "Industry knowledge beneficial to dependency understanding."

As I was driving home from work yesterday, what I thought was a Public Service Announcement about smoking cessation came on the radio. What it turned out to be in actuality was an advertisement for nicotine gum. I thought to myself how misleading the ad was, and my concern suddenly turned to a feeling of betrayal and absolute anger when I heard them refer to the gum as "medicine" to help you get through your cravings. What a crock! And how many poor souls are going to buy into that??? They ought to be ashamed of themselves.

Before my cold turkey quit, I tried tearing off small pieces of nicotine gum (not wanting to chew a whole piece--like I was doing myself a big favor) and holding it between my lip and gum. I have no idea what other chemicals are contained in that stuff, but my gums are still sore from doing that. Aside from the ingestion of nicotine and prolonging withdrawal, I wonder if long-term use of that stuff is just as dangerous as using smokeless tobacco. Do we know if any studies have been done on the oral affects of that stuff?

Free and Healing 24 Days, 2 Hours and 37 Minutes
Extending my life 1 Day and 16 Hours
Not smoking 482 cigarettes
Saving $86.88

John (Gold)
John (Gold)

5:30 AM - Jul 27, 2003 #5

Sine Qua Non - The essential, crucial, or indispensable ingredient without which something would be impossible: "

The value I see in this 1972 RJR Planning Memo is in its repeated declaration that nicotine is the sine qua non of smoking, a fact that both of you - Rick and Peg - have pick-up on. Instead of having to believe us or some medical study, it allows those who thought they had a little habit see just how important the tobacco industry believed nicotine was for at least the past 31 years. Nicotine is not medicine nor some nasty little habit but truly is the sine qua non of smoking.

When it comes to us not villifying those within the tobacco and NRT industry it can be hard to not feel that we should have been told more by both industries but debating that issue here in a place where we have a single unified objective would needlessly undermine the group support experience. A significant number of our members work in stores and jobs where they have no choice but to sell nicotine products, including one of our managers. We want each of them to feel comfortable here too! John

Joined: 8:00 AM - Jan 16, 2003

6:00 AM - Jul 27, 2003 #6

The only one to blame for my addiction to nicotine is me.
Whether or not I knew that smoking was addictive has no place in my responsibility for what I put into my own body. I knew that it was bad for me...even though I did not realize that I was addicted. It's not anyone's fault but mine.
Putting blame on anyone or looking down on smokers is not going to help anything.
I totally understand that I am one puff away from active addiction at all times for the rest of my life.
Education is the key to unlocking positive change. Blame is useless.
Thanks for adding to my education, John.
6 and a half months today!
Last edited by Sal GOLD.ffn on 1:07 PM - Feb 15, 2009, edited 1 time in total.

John (Gold)
John (Gold)

11:13 PM - Feb 03, 2004 #7

The Law of Addiction
The administration of a drug to an addict will cause reestablishment of dependence upon the addictive substance.
Simply restated ...
Last edited by John (Gold) on 1:06 PM - Feb 15, 2009, edited 2 times in total.